TRIP13 and colorectal carcinoma: Other studies looking at cancers such as glioblastoma, colorectal carcinoma, osteosarcoma, non-small cell lung cancer, and hepatocellular carcinoma have shown that increased TRIP13 expression led to increased proliferation, migration, and invasion49–53.